Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago

[1]  H. Einsele,et al.  Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors , 2004, British journal of haematology.

[2]  T. Dalianis,et al.  Megakaryocyte chimerism after allogeneic stem cell transplantation in children , 2003, Pediatric transplantation.

[3]  山口 晃司.  Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation : Evaluation by flow cytometric analysis of intracellular WAS protein expression , 2003 .

[4]  P. Bader,et al.  Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience , 2003, Leukemia.

[5]  P. Pigeon,et al.  Normal human bone marrow CD34(+)CD133(+) cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro. , 2002, Experimental hematology.

[6]  J. V. Stone,et al.  Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. , 2001, Blood.

[7]  H. Einsele,et al.  Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT , 1998, Bone Marrow Transplantation.

[8]  A. Fischer,et al.  Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. , 1996, The Journal of pediatrics.

[9]  Stiehm Er,et al.  Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation. , 1996 .

[10]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. , 1994, Cell.

[11]  A. Fischer,et al.  Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. , 1991, Blood.